SAN DIEGO, July 19, 2019 /PRNewswire/ -- Youngevity International, Inc. (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and its newly acquired commercial hemp enterprise, announced today that it executed a one year Supply and Processing Agreement to produce water soluble CBD (No

WASHINGTON, July 19, 2019 /PRNewswire/ -- Today, the American College of Surgeons (ACS) launched its new Geriatric Surgery Verification (GSV) Program at the ACS Quality and Safety Conference. This new surgical quality improvement program introduces 30 new surgical standards designed to systematically improve surgical care and outcomes for the aging adult population.

BALTIMORE, July 19, 2019 /PRNewswire/ -- Senior Helpers®, the nation's premier provider of in-home senior services, held the official groundbreaking event in

OCOEE, Fla., July 19, 2019 /PRNewswire/ -- Transaction Data Systems (TDS), parent company of the Rx30 and Computer-Rx pharmacy management systems, today announced a partnership that will provide an easy and efficient prescription delivery solution to more than 8,000 community pharmacies.

CHAMPIONSGATE, Fla., July 19, 2019 /PRNewswire/ -- Research published this week in the peer-reviewed Journal of Occupational Medicine and Toxicology (JOMT) shows that the safety thresholds for mercury exposure can be exceeded during dental procedures involving drilling on amalgam fillings if special precautions are not in place, according to the International Academy of Oral Medicine and Toxicolo

SUNNYVALE, Calif., July 19, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2019 ended June 30, 2019 on Thursday, August 15, 2019 after the market close. Management will host a conference call to review the results at

DUBLIN, July 19, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the third quarter of 2019. The dividend will be paid on September 13, 2019 to shareholders of record at the close of business on

SAN DIEGO, July 19, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that Janssen-Cilag International NV (Janssen) has submitted an extension application to the European Medicines Agency (EMA) for the subcutaneous delivery of DARZALEX® (daratumuma

SAN JOSE, Calif., July 19, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation to AR-501, the Company's inhaled formulation of gallium citrate for treatment of lung infection in patients with cystic fibrosis. This past June, Aridis also received Orphan Dr

MIAMI BEACH, Fla., July 19, 2019 /PRNewswire/ -- The next frontier in ischemic stroke therapy, advances in stenting, and innovations in cerebrospinal fluid imaging and diagnostics are a few of the topics that will be covered at the Society of NeuroInterventional Surgery's (SNIS) 16th Annual Meeting in Miami Beach from July 22–2